SARS-CoV-2 nsp13-IN-1

Modify Date: 2025-09-30 18:02:02

SARS-CoV-2 nsp13-IN-1 Structure
SARS-CoV-2 nsp13-IN-1 structure
Common Name SARS-CoV-2 nsp13-IN-1
CAS Number 1005304-44-8 Molecular Weight 432.47
Density N/A Boiling Point N/A
Molecular Formula C27H20N4O2 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of SARS-CoV-2 nsp13-IN-1


SARS-CoV-2 nsp13-IN-1 (compound C1) is a potent nsp13 (non-structural protein 13) inhibitor. SARS-CoV-2 nsp13-IN-1 only inhibits nsp13 ssDNA+ ATPase, with an IC50 of 6 μM. SARS-CoV-2 nsp13-IN-1 does not inhibit ssDNA- ATPase. SARS-CoV-2 nsp13-IN-1 can be used for COVID-19 research[1].

 Names

Name SARS-CoV-2 nsp13-IN-1

 SARS-CoV-2 nsp13-IN-1 Biological Activity

Description SARS-CoV-2 nsp13-IN-1 (compound C1) is a potent nsp13 (non-structural protein 13) inhibitor. SARS-CoV-2 nsp13-IN-1 only inhibits nsp13 ssDNA+ ATPase, with an IC50 of 6 μM. SARS-CoV-2 nsp13-IN-1 does not inhibit ssDNA- ATPase. SARS-CoV-2 nsp13-IN-1 can be used for COVID-19 research[1].
Related Catalog
Target

IC50: 6 ± 0.5 μM (nsp13 ssDNA+ ATPase)[1]

References

[1]. Yazdi AK, et al. Kinetic Characterization of SARS-CoV-2 nsp13 ATPase Activity and Discovery of Small-Molecule Inhibitors. ACS Infect Dis. 2022 Jul 13.

 Chemical & Physical Properties

Molecular Formula C27H20N4O2
Molecular Weight 432.47
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.